Summary
Studies on the interaction of two dopamine (DA) agonists (selected as most specific): apomorphine (APO) and 1, 3-dimethyl-5-aminoadamantane (DMAA) with serotonin (5-HT) and noradrenaline (NA) brain systems have revealed that the drugs induce the activation of 5-HT and NA neurons in an indirect way (via primary DA stimulation). These interactions are relevant for some pharmacological effects of DA agonists.
Similar content being viewed by others
References
Grabowsky, M.: Influence of midbrain raphe lesion on some pharmacological and biochemical effects of apomorphine in rats. Psychopharmacol. (Berl.) 39, 315–322 (1974)
Grabowsky, M.: Influence of apomorphine on brain serotonin turnover rate. Pharmacol. Biochem. Behav. 3, 589–591 (1975)
Grabowska, M., Antkiewicz, L., Maj, J., Michaluk, J.: Apomorphine and central serotonin neurons. Pol. J. Pharmacol. Pharm. 25, 29–39 (1973)
Hill, H. F., Horita, A.: A pimozide-sensitive effect of apomorphine on body temperature of the rabbit. J. Pharm. Pharmacol. 24, 490–491 (1972)
Maj, J.: Dopaminergic drug effects upon serotoninergic neurons. In: Current Developments in Psychopharmacology, eds. W. Essman and Valzelli, Spectrum Publications Inc., N. Y., vol. 3 (1976) in press
Maj, J., Grabowsky, M., Gajda, L.: Effect of apomorphine on motility in rats. Europ. J. Pharmacol. 17, 208–214 (1972)
Maj, J., Marchaj, J., Mogilnicka, E.: The effect of dimethyl-aminoadamantan on the brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels. In: Symposium on Pharmacology of catecholaminergic and serotonergic mechanisms eds. Knoll, J. and Magyar, K., Akademiai Kiado-Budapest, p. 115–119 (1976)
Maj, J., Mogilnicka, E., Klimek, V.: The effect of apomorphine and dimethylaminoadamantan on brain noradrenaline in the rat. Pol. J. Pharmacol. Pharm., in press
Maj, J., Pawlowski, L.: The hypothermic effect of L-DOPA in the rat. Life Sci. 13, 141–149 (1973)
Maj, J., Przewlocka, B.: The action of L-DOPA in rats with the raphe nuclei lesions. Pol. J. Pharmacol. Pharm. 27 (suppl.) 151–154 (1975)
Mogilnicka, E., Braestrup, C.: Noradrenergic influences on the stereotyped behaviour induced by amphetamine phenylethylamine and apomorphine. J. Pharm. Pharmacol. 28, 253–255 (1976)
Mogilnicka, E., Klimek, V., Golembiowska, K., Scheel-Krüger, J.: The effect of serotonin antagonists on the action of dopaminergic drugs. Pol. J. Pharmacol. Pharm., in press
Persson, T., Waldeck, B.: Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain. Europ. J. Pharmacol. 11, 315–320 (1970)
Przewlocki, R.: The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane on ponto-geniculo-occipital (PGO) waves in cats. Pol. J. Pharmacol. Pharm. 27 (suppl.), 201–207 (1975)
Przewlocki, R.: Dopaminergic and serotoninergic mechanisms of hypothermia induced by dopamine agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 294 (suppl.), 16 (1976)
Smialowska, M.: Histochemical studies on the effect of apomorphine and dimethylaminoadamantane on catecholamines and serotonin in rat brain. Doctoral thesis, Polish Academy of Sciences, Cracov, pp 1–87 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maj, J. Dopamine agonists and interaction with other neurotransmitter systems. Naunyn-Schmiedeberg's Arch. Pharmacol. 297 (Suppl 1), S53–S54 (1977). https://doi.org/10.1007/BF00587777
Issue Date:
DOI: https://doi.org/10.1007/BF00587777